Dr. Ritu Modi, M.D Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 521 Moye Blvd, Greenville, NC 27834 Phone: 252-744-1600 Fax: 252-744-1115 |
Dr. Hamed Ali, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 521 Moye Blvd Fl 1, Ecu Physicians Pulmonary & Critical Care, Greenville, NC 27834 Phone: 252-744-1600 Fax: 252-744-1115 |
Dr. Frank Joseph Lodeserto, Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Stantonsburg Rd, Ecu Physicians Critical Care, Greenville, NC 27834 Phone: 252-744-1600 Fax: 252-744-1115 |
Anupama Tiwari, Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 521a Moye Blvd, Greenville, NC 27834 Phone: 252-744-1600 Fax: 252-744-1115 |
Dr. Elise Loraine Stephenson, M.D. Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 521 Moye Blvd, Greenville, NC 27834 Phone: 252-744-1600 Fax: 252-744-1115 |
Thomson C Pancoast, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 521 Moye Blvd, Greenville, NC 27834 Phone: 252-744-1600 Fax: 252-744-1115 |
Mark A Mazer, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 521 Moye Blvd Fl 1, Ecu Physicians Pulmonary/critical Care, Greenville, NC 27834 Phone: 252-744-1600 Fax: 252-744-1115 |
News Archive
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.
A research collaboration based in Japan has found a new pathological mediator of amyotrophic lateral sclerosis, which could have further implications for understanding the molecular breakdown that gives rise to the neurodegenerative disease that affects nearly half a million people around the world.
After a limb amputation, brain areas responsible for movement and sensation alter their functional communication. This is the conclusion of a new study published today in Scientific Reports.
Diabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications.
› Verified 5 days ago